(Q46877696)

26 December 2017

title

Endocrine-metabolic effects of the treatment with pioglitazone in obese patients with polycystic ovary syndrome (English)

1 reference

26 December 2017

polycystic ovary syndrome

main subject

obesity

0 references

1 reference

1 reference

Heraldo M Garmes

1

1 reference

26 December 2017

Marcos A Tambascia

series ordinal

2

1 reference

26 December 2017

Denise E Zantut-Wittmann

series ordinal

3

1 reference

26 December 2017

language of work or name

1 reference

1 December 2005

1 reference

26 December 2017

Gynecological Endocrinology

published in

1 reference

26 December 2017

volume

21

1 reference

26 December 2017

issue

6

1 reference

26 December 2017

page(s)

317-323

1 reference

26 December 2017

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

Menstrual cyclicity after metformin therapy in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

Pioglitazone and sodium salicylate protect human beta-cells against apoptosis and impaired function induced by glucose and interleukin-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

Polycystic ovary syndrome: a changing perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

Role of brain insulin receptor in control of body weight and reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

Clinical assessment of body hair growth in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

Insulin-lowering drugs in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

Induction of steroidogenic enzyme genes by insulin and IGF-I in cultured adult human adrenocortical cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3beta -hydroxysteroid dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

IRS-2 pathways integrate female reproduction and energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500430575

10.1080/09513590500430575

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017